335254-69-8

Basic information

• Product Name: tert-butyl (4-iodo-2-nitrophenyl)carbaMate
• Synonyms: tert-butyl (4-iodo-2-nitrophenyl)carbaMate;(4-Iodo-2-nitrophenyl)carbamic acid tert-butyl ester
• CAS NO: 335254-69-8
• Molecular Formula: C₁₁H₁₃IN₂O₄
• Molecular Weight: 364.13639
• EINECS: -0
• Mol File: 335254-69-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: tert-butyl (4-iodo-2-nitrophenyl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (4-iodo-2-nitrophenyl)carbaMate(335254-69-8)
• EPA Substance Registry System: tert-butyl (4-iodo-2-nitrophenyl)carbaMate(335254-69-8)

Safety Data

• Hazardous Substances Data: 335254-69-8(Hazardous Substances Data)

Usage

General Description

Tert-butyl (4-iodo-2-nitrophenyl)carbamate is a chemical compound with the molecular formula C13H16IN2O4. It is a carbamate derivative containing a tert-butyl group attached to a 4-iodo-2-nitrophenyl group. tert-butyl (4-iodo-2-nitrophenyl)carbaMate is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals and agrochemicals. It is often employed as a reagent in the synthesis of biologically active compounds due to its versatility and stability. Tert-butyl (4-iodo-2-nitrophenyl)carbamate may also have potential applications in materials science and chemical research.

Upstream product

• 88-74-4 2-nitro-aniline 
• 20691-72-9 4-iodo-2-nitroaniline 
• 75-65-0 tert-butyl alcohol 
• 503-38-8 trichloromethyl chloroformate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 335254-77-8 tert-butyl (3-nitro-[1, 1'-biphenyl]-4-yl)carbamate 
• 335254-91-6 (4-benzofuran-2-yl-2-nitro-phenyl)-carbamic acid tert.-butyl ester 
• 335254-74-5 (2-nitro-4-thiophen-3-yl-phenyl)-carbamic acid tert.-butyl ester 
• 335254-79-0 (4-naphthalen-1-yl-2-nitro-phenyl)-carbamic acid tert.-butyl ester 
• 335255-08-8 (4-benzoyl-2-nitro-phenyl)-carbamic acid tert.-butyl ester 
• 335255-09-9 (2-nitro-4-tributylstannanyl-phenyl)-carbamic acid tert.-butyl ester 
• 1453393-66-2 4-[3’-(1''H-imidazol-1''-yl)phenyl]-8-(3'''-iodophenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one 
• 1453393-68-4 4-[3’-(1''H-imidazol-1''-yl)phenyl]-8-(4'''-iodophenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one 
• 1453393-54-8 4-[3’-(1''H-imidazol-1''-yl)phenyl]-8-iodo-2,3-dihydro-1H-1,5-benzodiazepin-2-one 
• 1453393-56-0 8-(3'''-bromophenyl)-4-[3’-(1''H-imidazol-1''-yl)phenyl]-2,3-dihydro-1H-1,5-benzodiazepin-2-one 
• 1453393-58-2 8-(4'''-bromophenyl)-4-[3’-(1''H-imidazol-1''-yl)phenyl]-2,3-dihydro-1H-1,5-benzodiazepin-2-one 
• 1453393-89-9 1-(tert-butoxycarbonylamino)-2-{3’-[3''-(1'''H-imidazol-1'''-yl)phenyl]-3'-oxopropanamido}-4-iodobenzene 
• 1453393-91-3 4-(3''''-bromophenyl)-1-(tert-butoxycarbonylamino)-2-{3’-[3''-(1'''H-imidazol-1'''-yl)phenyl]-3’-oxopropanamido}benzene 
• 1453393-93-5 4-(4''''-bromophenyl)-1-(tert-butoxycarbonylamino)-2-{3’-[3''-(1'''H-imidazol-1'''-yl)phenyl]-3’-oxopropanamido}benzene 

Relevant articles and documents

New class of bioluminogenic probe based on bioluminescent enzyme-induced electron transfer: BioLeT

Bioluminescence imaging (BLI) has advantages for investigating biological phenomena in deep tissues of living animals, but few design strategies are available for functional bioluminescent substrates. We propose a new design strategy (designated as bioluminescent enzyme-induced electron transfer: BioLeT) for luciferin-based bioluminescence probes. Luminescence measurements of a series of aminoluciferin derivatives confirmed that bioluminescence can be controlled by means of BioLeT. Based on this concept, we developed bioluminescence probes for nitric oxide that enabled quantitative and sensitive detection even in vivo. Our design strategy should be applicable to develop a wide range of practically useful bioluminogenic probes.

NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF

The present invention relates to novel benzodiazepinone compounds of Formulae (I) wherein R1, R2, R4, R6, R7, R8, R9, and R10 are as defined herein. The invention also

Glutamate receptor antagonists

The present invention relates to compounds of with a base structure of formula 1 The compounds of formula I are shown to have activity as metabotropic glutamate receptor antagonists.